DK2132562T3 - Fremgangsmåder til at vurdere celler og cellekulturer - Google Patents

Fremgangsmåder til at vurdere celler og cellekulturer

Info

Publication number
DK2132562T3
DK2132562T3 DK08733105.4T DK08733105T DK2132562T3 DK 2132562 T3 DK2132562 T3 DK 2132562T3 DK 08733105 T DK08733105 T DK 08733105T DK 2132562 T3 DK2132562 T3 DK 2132562T3
Authority
DK
Denmark
Prior art keywords
methods
cell cultures
assessing cells
assessing
cells
Prior art date
Application number
DK08733105.4T
Other languages
English (en)
Inventor
Stephen M Rapko
Stephen J Duguay
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of DK2132562T3 publication Critical patent/DK2132562T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4722—Proteoglycans, e.g. aggreccan
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
DK08733105.4T 2007-04-06 2008-04-03 Fremgangsmåder til at vurdere celler og cellekulturer DK2132562T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91057407P 2007-04-06 2007-04-06
PCT/US2008/059275 WO2008124508A1 (en) 2007-04-06 2008-04-03 Methods of evaluating cells and cell cultures

Publications (1)

Publication Number Publication Date
DK2132562T3 true DK2132562T3 (da) 2012-04-30

Family

ID=39629001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08733105.4T DK2132562T3 (da) 2007-04-06 2008-04-03 Fremgangsmåder til at vurdere celler og cellekulturer

Country Status (21)

Country Link
US (3) US8029992B2 (da)
EP (2) EP2442104A3 (da)
JP (2) JP5383654B2 (da)
KR (1) KR20090127153A (da)
CN (1) CN101680881B (da)
AR (1) AR066403A1 (da)
AT (1) ATE541211T1 (da)
AU (1) AU2008237332A1 (da)
BR (1) BRPI0809902A2 (da)
CA (1) CA2682948C (da)
DK (1) DK2132562T3 (da)
ES (1) ES2380753T3 (da)
HK (1) HK1138374A1 (da)
HR (1) HRP20120299T1 (da)
IL (1) IL201225A0 (da)
MX (1) MX2009010694A (da)
MY (1) MY153234A (da)
PL (1) PL2132562T3 (da)
PT (1) PT2132562E (da)
SI (1) SI2132562T1 (da)
WO (1) WO2008124508A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006007560A2 (en) 2004-07-01 2006-01-19 University Of Pennsylvania Targeted protein replacement for the treatment of lysosomal storage disorders
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
JP5557084B2 (ja) * 2009-03-17 2014-07-23 独立行政法人物質・材料研究機構 組織再生方法
US20120128632A1 (en) * 2009-07-23 2012-05-24 Jeffrey Keeler Teumer Identity markers
EP2552472A4 (en) * 2010-03-29 2014-03-12 Massachusetts Inst Technology ANTI-INFLAMMATORY FACTORS
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
KR20140023260A (ko) * 2010-11-16 2014-02-26 미쓰비시 가가꾸 가부시키가이샤 Cartilage Acidic Protein 1 단백질에 의한 뇌경색의 검사 방법
KR101316702B1 (ko) * 2011-04-20 2013-10-10 서울대학교산학협력단 곤충의 표지 유전자를 이용한, 곤충의 맥주 유입 시기 계산 방법
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
SI2753346T1 (sl) 2011-09-07 2020-09-30 Mount Sinai School Of Medicine Ceramidaza in diferenciacija celic
CA2874146C (en) 2012-06-01 2023-03-21 Icahn School Of Medicine At Mount Sinai Ceramide levels in the treatment and prevention of infections
CA2905449A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Therapeutic acid ceramidase compositions and methods of making and using them
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
DE102016213684A1 (de) * 2016-07-26 2018-02-01 Tetec Tissue Engineering Technologies Ag Marker und Verfahren zur Beurteilung der Zusammensetzung oder Reinheit einer Zellkultur sowie zur in vitro Bestimmung der Identität einer Knorpelzelle oder einer Synovialzelle
JP2020514739A (ja) * 2017-03-06 2020-05-21 ハプルサイエンス・インコーポレイテッド Ｈａｐｌｎ１を利用した皮膚老化の測定用または予防用または改善用の組成物
EP3417888A1 (de) * 2017-06-25 2018-12-26 co.don AG Verfahren zum herstellen von transplantierbarem knorpelgewebe
CN112048563B (zh) * 2020-09-09 2022-12-02 福建华民生物科技有限公司 一种利用软骨特异性基因表达程度控制软骨质量的方法
JP7222001B2 (ja) * 2021-01-22 2023-02-14 ハプルサイエンス・インコーポレイテッド Ｈａｐｌｎ１を利用した皮膚老化の測定用または予防用または改善用の組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004681A2 (en) 1996-07-25 1998-02-05 Genzyme Corporation Chondrocyte media formulations and culture procedures
EP0956364A1 (en) * 1996-07-26 1999-11-17 Genzyme Corporation Whole cell assay
US20030087259A1 (en) * 2001-04-18 2003-05-08 Clancy Brian M. Methods and compositions for regulating bone and cartilage formation
BRPI0307074A2 (pt) 2002-01-25 2017-06-20 Genzyme Corp meios sem soro para condrócitos e métodos para seu uso
EP1863924A2 (en) * 2005-03-11 2007-12-12 Epiontis GmbH Specific dnas for epigenetic characterisation of cells and tissues
JP5190654B2 (ja) * 2005-03-31 2013-04-24 国立大学法人広島大学 分子マーカーを用いた間葉系幹細胞の識別方法及びその利用
WO2007058671A1 (en) * 2005-11-21 2007-05-24 West Michael D Novel uses of cells with prenatal patterns of gene expression
BRPI0713572A2 (pt) 2006-06-20 2012-10-23 Stephen Duguay meios livres de soro e seus usos para expansão de condrócitos

Also Published As

Publication number Publication date
CN101680881B (zh) 2013-04-24
PT2132562E (pt) 2012-04-19
ES2380753T3 (es) 2012-05-18
ATE541211T1 (de) 2012-01-15
BRPI0809902A2 (pt) 2014-10-07
EP2132562B1 (en) 2012-01-11
EP2132562A1 (en) 2009-12-16
EP2442104A3 (en) 2012-04-25
CA2682948C (en) 2016-05-31
MY153234A (en) 2015-01-29
JP5383654B2 (ja) 2014-01-08
CA2682948A1 (en) 2008-10-16
JP2010523124A (ja) 2010-07-15
SI2132562T1 (sl) 2012-05-31
AR066403A1 (es) 2009-08-19
US20080248481A1 (en) 2008-10-09
PL2132562T3 (pl) 2012-06-29
US8029992B2 (en) 2011-10-04
US20120149013A1 (en) 2012-06-14
US20120329051A1 (en) 2012-12-27
HRP20120299T1 (hr) 2012-04-30
EP2442104A2 (en) 2012-04-18
JP2014036658A (ja) 2014-02-27
CN101680881A (zh) 2010-03-24
ES2380753T9 (es) 2012-11-27
HK1138374A1 (en) 2010-08-20
MX2009010694A (es) 2009-10-22
EP2132562B9 (en) 2012-05-23
WO2008124508A1 (en) 2008-10-16
IL201225A0 (en) 2010-05-31
AU2008237332A1 (en) 2008-10-16
KR20090127153A (ko) 2009-12-09

Similar Documents

Publication Publication Date Title
DK2132562T3 (da) Fremgangsmåder til at vurdere celler og cellekulturer
DK2574677T3 (da) Fremgangsmåder til celledyrkning
DK2271933T3 (da) System og fremgangsmåde til cellekarakterisering
BRPI0821262A2 (pt) Célula fotovoltaica e dispositivo fotovoltaico
IL200031A0 (en) Electrochemical cell and method for operating the same
DK1905117T3 (da) Forbedrede perfluorerede membraner og forbedrede elektrolytter til redoxceller og batterier
EP2260528A4 (en) ELECTROCHEMICAL CELL AND THE SAME MEMBRANES
DK3061808T3 (da) Dyrkningsmedium til epitelstamceller og organoider omfattende disse stamceller
DK4209510T3 (da) Anti-pd-l1-antistoffer og deres anvendelse til at fremme t-cellefunktion
DK2078073T3 (da) Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering
DE602007004421D1 (de) Zellkulturvorrichtung
EP2212963A4 (en) ELECTROCHEMICAL CELL WITH QUASIPOLAR STRUCTURE
DK1952103T3 (da) Fremgangsmåde til at veje med flere vejeceller
DE602008003645D1 (de) Elektrolytmembran für Brennstoffzelle und Brennstoffzelle enthaltend diesselbe
DK2313956T3 (da) Forbedringer til og vedrørende batteristyring
EP2162531A4 (en) METHOD AND MEANS FOR CULTURING OSTEOBLASTS
DK2071216T3 (da) Superplastisk pakning, fortrinsvis til et system med elektrokemiske celler
DE112008002984B8 (de) Separator für Brennstoffzelle und Brennstoffzelle
EP2245686A4 (en) COVERS FOR ELECTROCHEMICAL CELLS AND RELATED METHODS
DK1739774T3 (da) Brændselscelletætning og plade
EP2210309A4 (en) BATTERY CELL WITH QUASI-BIPOLAR CONSTRUCTION
EP2151004A4 (en) ELECTROCHEMICAL CELLS AND METHOD FOR PRODUCING FUEL
DE602008002852D1 (de) Brennstoffzellsystem
DE602007008627D1 (de) Zellkulturmedium
IL205610A0 (en) Methods of measuring cell viability without using control cells